BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22311584)

  • 21. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
    Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
    Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers.
    Chang L; Chang M; Chang HM; Chang F
    J Gastrointest Cancer; 2017 Dec; 48(4):305-313. PubMed ID: 28699072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
    Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
    Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study.
    Nakayama Y; Iijima T; Inokuchi T; Kojika E; Takao M; Takao A; Koizumi K; Horiguchi SI; Hishima T; Yamaguchi T
    Int J Clin Oncol; 2021 Oct; 26(10):1881-1889. PubMed ID: 34148153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor histology helps to identify Lynch syndrome among colorectal cancer patients.
    Truta B; Chen YY; Blanco AM; Deng G; Conrad PG; Kim YH; Park ET; Kakar S; Kim YS; Velayos F; Sleisenger MH; Terdiman JP
    Fam Cancer; 2008; 7(3):267-74. PubMed ID: 18283560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?
    Brazowski E; Rozen P; Pel S; Samuel Z; Solar I; Rosner G
    Fam Cancer; 2012 Jun; 11(2):249-57. PubMed ID: 22246243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical utility of microsatellite instability in colorectal cancer.
    Diao Z; Han Y; Chen Y; Zhang R; Li J
    Crit Rev Oncol Hematol; 2021 Jan; 157():103171. PubMed ID: 33290824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
    Hartman DJ; Brand RE; Hu H; Bahary N; Dudley B; Chiosea SI; Nikiforova MN; Pai RK
    Hum Pathol; 2013 Nov; 44(11):2518-28. PubMed ID: 24034859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
    Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
    Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer.
    van Putten PG; van Lier MG; Hage M; Biermann K; van Rijssel RH; Westenend PJ; Morreau H; Steyerberg EW; Dinjens WN; Kuipers EJ; van Leerdam ME; van Krieken JH
    Fam Cancer; 2014 Sep; 13(3):351-9. PubMed ID: 24638969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.
    Beamer LC; Grant ML; Espenschied CR; Blazer KR; Hampel HL; Weitzel JN; MacDonald DJ
    J Clin Oncol; 2012 Apr; 30(10):1058-63. PubMed ID: 22355048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
    Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
    JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.
    Zhang L
    J Mol Diagn; 2008 Jul; 10(4):301-7. PubMed ID: 18556776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumour examination to detect hereditary colorectal cancer].
    Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
    Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.
    Matsubayashi H; Higashigawa S; Kiyozumi Y; Oishi T; Sasaki K; Ishiwatari H; Imai K; Hotta K; Yabuuchi Y; Ishikawa K; Satoh T; Ono H; Todaka A; Kawakami T; Shirasu H; Yasui H; Sugiura T; Uesaka K; Kagawa H; Shiomi A; Kado N; Hirashima Y; Kiyohara Y; Bando E; Niwakawa M; Nishimura S; Aramaki T; Mamesaya N; Kenmotsu H; Horiuchi Y; Serizawa M
    BMC Cancer; 2022 Jan; 22(1):73. PubMed ID: 35039004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
    Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
    Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
    de Bruin JH; Kievit W; Ligtenberg MJ; Nagengast FM; Adang EM; Ruers TJ; Kleibeuker JH; Sijmons RH; van Krieken JH; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1792-8. PubMed ID: 16121665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.